Safety and efficacy of a docetaxel-5FU-oxaliplatin regimen with or without trastuzumab in neoadjuvant treatment of localized gastric or gastroesophageal junction cancer: A retrospective study

BACKGROUND: Triplet chemotherapy, with docetaxel-5FU-oxaliplatin FLOT regimen recently became the standard perioperative treatment for localized gastric cancer (GC). An adapted regimen called TeFOX was recently tested in metastatic setting and gave promising results. AIM: To determine safety and eff...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:World J Gastrointest Oncol
Asıl Yazarlar: Basso, Valeria, Orry, David, Fraisse, Jean, Vincent, Julie, Hennequin, Audrey, Bengrine, Leila, Ghiringhelli, Francois
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Inc 2019
Konular:
Retrospective Study
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6700033/
https://ncbi.nlm.nih.gov/pubmed/31435464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v11.i8.634
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller